| 1 | [SID85736331] | Active | Potency | 0.1995 | Confirmation qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2677, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Active | | Potency | 0.1995 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2677 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 2 | [SID85736331] | Active | Potency | 0.3 | AlphaScreen Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2687, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Active | | Potency | 0.3 [uM] | | BioAssay | AlphaScreen Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2687 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 3 | [SID85736331] | Active | Potency | 1.122 | Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E): 8HQs - Round 1 [AID493212, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Active | | Potency | 1.122 [uM] | | BioAssay | Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E): 8HQs - Round 1 | | AID | 493212 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 4 | [SID90419359] | Active | Potency | 1.6231 | Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E): 8HQs - Round 1 [AID493212, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 90419359 | | CID | 459617 | | Outcome | Active | | Potency | 1.6231 [uM] | | BioAssay | Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E): 8HQs - Round 1 | | AID | 493212 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 5 | [SID85736331] | Active | Potency | 2.586 | MALDI-TOF-MS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2688, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Active | | Potency | 2.586 [uM] | | BioAssay | MALDI-TOF-MS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2688 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 6 | [SID85736331] | Active | Potency | 5.6234 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 7 | [SID90419359] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 90419359 | | CID | 459617 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 8 | [SID85736331] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 9 | [SID85736331] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 10 | [SID99495762] | Active | | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity [AID602393, Type: screening] | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Active | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602393 | | BioAssay type | screening | | Target | transcription activator BRG1 isoform 1 [Mus musculus] [gi:291463269] | | PubMed | | | Data Table |  |
|
| 11 | [SID99495762] | Active | AbsAC40_uM | | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_Dose_CherryPick_Activity [AID651717, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Active | | AbsAC40_uM | [uM] | | BioAssay | Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_Dose_CherryPick_Activity | | AID | 651717 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID99495762] | Inactive | | | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity [AID651723, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity | | AID | 651723 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID99495762] | Inactive | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID99495762] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID99495762] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID99495762] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID99495762] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID99495762] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID99495762] | Inactive | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID99495762] | Inactive | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID99495762] | Inactive | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID99495762] | Inactive | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID99495762] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID99495762] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID686964, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide | | AID | 686964 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID85736331] | Inactive | Potency | | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 26 | [SID90419359] | Inactive | Potency | | Counterscreen for JMJD2E Inhibitors: qHTS Assay for Inhibitors of Formaldehyde Dehydrogenase (FDH) [AID2680, Type: confirmatory] | formaldehyde dehydrogenase [Pseudomonas putida] [gi:416247] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 90419359 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Counterscreen for JMJD2E Inhibitors: qHTS Assay for Inhibitors of Formaldehyde Dehydrogenase (FDH) | | AID | 2680 | | BioAssay type | confirmatory | | Target | formaldehyde dehydrogenase [Pseudomonas putida] [gi:416247] | | PubMed | | | Data Table |  |
|
| 27 | [SID85736331] | Inactive | Potency | | Counterscreen for JMJD2E Inhibitors: qHTS Assay for Inhibitors of Formaldehyde Dehydrogenase (FDH) [AID2680, Type: confirmatory] | formaldehyde dehydrogenase [Pseudomonas putida] [gi:416247] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Counterscreen for JMJD2E Inhibitors: qHTS Assay for Inhibitors of Formaldehyde Dehydrogenase (FDH) | | AID | 2680 | | BioAssay type | confirmatory | | Target | formaldehyde dehydrogenase [Pseudomonas putida] [gi:416247] | | PubMed | | | Data Table |  |
|
| 28 | [SID99495762] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 29 | [SID99495762] | Inactive | | | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID624204, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 624204 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 30 | [SID85736331] | Inactive | Potency | | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 31 | [SID99495762] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 32 | [SID99495762] | Inactive | Potency | | qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory] | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of Trypanosoma Brucei Inhibitors | | AID | 624173 | | BioAssay type | confirmatory | | Target | hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610] | | PubMed | | | Data Table |  |
|
| 33 | [SID99495762] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 34 | [SID99495762] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) [AID652067, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) | | AID | 652067 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 35 | [SID99495762] | Inactive | | | PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity [AID602405, Type: screening] | WlaI protein (PglD) [gi:75495260] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602405 | | BioAssay type | screening | | Target | WlaI protein (PglD) [gi:75495260] | | PubMed | | | Data Table |  |
|
| 36 | [SID99495762] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 37 | [SID85736331] | Inactive | Potency | | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 38 | [SID85736331] | Inactive | Potency | | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) [AID485294, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85736331 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) | | AID | 485294 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 39 | [SID99495762] | Inactive | | | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity [AID652162, Type: screening] | Toxin B [Clostridium difficile 630] [gi:126698238] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652162 | | BioAssay type | screening | | Target | Toxin B [Clostridium difficile 630] [gi:126698238] | | PubMed | | | Data Table |  |
|
| 40 | [SID99495762] | Inactive | | | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay [AID602438, Type: screening] | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay | | AID | 602438 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] | | PubMed | | | Data Table |  |
|
| 41 | [SID90419359] | Inactive | Potency | | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 90419359 | | CID | 459617 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID99495762] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID99495762] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID99495762] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID99495762] | Inactive | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID99495762] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID99495762] | Inactive | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID99495762] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID99495762] | Inactive | | | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602247, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602247 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID99495762] | Inactive | | | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602248, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99495762 | | CID | 459617 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602248 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|